Publications
- New therapies in cystic fibrosis2023 | Second Faculty of Medicine
- Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis2022 | Second Faculty of Medicine
- Mucus release and airway constriction by tmem16a may worsen pathology in inflammatory lung disease2021 | Second Faculty of Medicine
- Ventilation Inhomogeneity and Bronchial Basement Membrane Changes in Chronic Neutrophilic Airway Inflammation2020 | Second Faculty of Medicine
- Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A > G2020 | Second Faculty of Medicine
- Mutant CFTR Drives TWIST1 mediated epithelial-mesenchymal transition2020 | Second Faculty of Medicine
- Assessment of Distinct Electrophysiological Parameters in Rectal Biopsies for the Choice of the Best Diagnosis/Prognosis Biomarkers for Cystic Fibrosis2020 | Second Faculty of Medicine
- Ivacaftor in adults with cystic fibrosis: a ten-year follow-pu of lung function and nutritional sttus2020 | Second Faculty of Medicine
- New possibilities of cystic fibrosis treatment +12020 | Second Faculty of Medicine
- TMEM16A in Cystic Fibrosis: Activating or Inhibiting?2019 | Second Faculty of Medicine
Loading network view...